evolocumab
Early Treatment With Repatha Lowered Incidence of CV Death, Other Events
Long-term treatment with evolocumab in adults with atherosclerosis lowered the incidence of major cardiovascular ...
SEPTEMBER 8, 2022
Abarca, Amgen Bet on PCSK9 Outcomes
Innovative pharmacy benefits manager (PBM) Abarca has entered into an outcomes-based contract for the proprotein ...
APRIL 11, 2018
New Indication Granted for Repatha for Wider Group of Patients: Adults with CVD
Repatha's indication had been limited to patients with homozygous familial hypercholesterolemia who require ...
DECEMBER 2, 2017
Amgen Wins Next Step in Patent Dance Over PCSK9 Drugs
Despite the win, the case is long from over; Sanofi and Regeneron plan to appeal.
MARCH 24, 2016
Evolocumab Reduces LDL in Patients With Diabetes
Will PCSK9 drug inhibitors make a difference in how we treat type 2 diabetes?
FEBRUARY 26, 2016
